Problem to be solved. To provide an anxiolytic pharmaceutical composition using a safe and easily available anxiolytic compound and a processed food using the same. Solution. An anxiolytic pharmaceutical composition comprises at least one anxiolytic compound selected from 2-ethyl-3,5-dimethyl pyrazine, 2-ethyl-3,6-dimethyl pyrazine, 2,3,5-trimethyl pyrazine, 2,3-diethyl-5-methyl pyrazine, 3,7-dimethyl-2,6-octadiene-1-ol, and 4-hydroxy-2,5-dimethyl-3 (2H)-furanone, which have been found to be compounds with anxiolytic activity. A processed food uses the anxiolytic pharmaceutical composition. Both the anxiolytic pharmaceutical composition and the processed food using the same can exert sedative neurological effects, such as sedation/hypnosis, anticonvulsion, and antianxiety, in the absence of catechins which are GABAA receptor inhibitors.

You do not currently have access to this content.